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In this issue of the Journal, Corrado et al. (1) have described
a prospective cohort study conducted in Veneto Region of
Italy from 1979 to 1999 comparing sudden death (SD) in
competitive athletes versus non-athletes in the range of 12
to 35 years of age. The study was well powered at approx-
imately 29,000,000 person-years. The prospective cohort
design was also optimal in addressing the study question,
drawing on a comprehensive sports medicine database and
using a small and experienced group of cardiac pathologists
to provide a highly accurate final diagnosis. In the unique
Veneto database, all participants ages 12 to 35 years in an
organized sports program requiring regular training and
competition undergo a preparticipation and subsequent
yearly history, physical examination, resting and (limited)
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exercise electrocardiogram, and pulmonary function studies
by a registered sports medicine specialist, as required by
Italian law (2). The population in this region is predomi-
nately white and ethnically homogeneous. After initial
postmortem examination at regional medical centers, all
cardiac specimens were examined at the Institute of Patho-
logical Anatomy of the University of Padua. The findings
were conclusive for the following: 1) young competitive
athletes were at significantly increased risk of all types of SD
compared with non-athletes (relative risk  2.5); 2) the
increased risk of all types of SD among athletes was
observed in both males and females (although not statisti-
cally significant in females); and 3) SD tends to be exercise
related and attributable to underlying cardiovascular pathol-
ogy in competitive athletes. Relative risk of cardiovascular
SD among athletes compared with non-athletes is 2.8.
Again, the increased risk of SD from cardiovascular diseases
was observed in both males and females. This study was able
to illustrate more definitively than other studies to date that
participation in competitive sports is associated with a
higher risk of SD in patients with a wide range of asymp-
tomatic cardiac disorders by sorting out the confounding
effects of male:female ratio among athletes and non-
athletes. Using Poisson regression analysis, no interaction
between sports participation and gender was found to be
significant. This study benefits from two distinct advantages
over previous studies on this subject. First, some form of
preparticipation screening has been mandated in Italy for
over 50 years and since 1971 has included a yearly compre-
hensive examination of both competitive and non-
competitive athletes. These evaluations are performed by
specifically trained physicians who are registered with the
Italian Sports Medicine Foundation (3). Thus, universal
preparticipation screening is entrenched in the culture, and
there is less likelihood for selection bias associated with
other cultural or economic variables. Second, the pathologic
studies of the heart specimen were performed by a single
program with impeccable technique in evaluating coronary
anatomy. These lesions may not be detected by the more
routine pathologic examination and, without such a rigorous
methodology, may be under appreciated as a cause of SD.
The use of person-years as an analytical unit may lead to
subtle biases. However, we think these biases may lead to a
more conservative estimate of SD risk for athletes and thus
not invalidate the authors’ conclusions based on the study.
Consider an individual who participated in sports at a highly
competitive level in high school and college but had with-
drawn from competitive sports because of injury at age 22.
This individual will contribute 9 person-years to the athletic
subsample and 14 person-years to the non-athletic sub-
sample. Suppose this individual died suddenly at age 35
from a coronary event; the SD event will be counted as
non-athlete SD, thus biasing the result. One can conceive of
other situations where the bias may occur in the opposite
direction. The likelihood of occurrence for each situation
will ultimately determine the direction of bias of the final
estimate.
Although this is a persuasive study, we believe that its
results and conclusions may not be completely generalizable
to the scale and diversity of the U.S. population for three
reasons. First, this study population is almost homoge-
neously white, whereas the U.S. athletic pool is racially,
ethnically, and culturally diverse. Each racial and ethnic
subgroup of athletes may have differential risks for under-
lying cardiovascular risks and SD risks. For example, the
population in Italy has a high incidence of arrhythmogenic
right ventricular dysplasia, which is thought to be the cause
of death in 15% of the patients in this study. In the U.S., a
large number of competitive athletes at the high school and
collegiate level are African American. Studies have shown
that among U.S. athletes with SD, 52% are white and 44%
are African American (4). The most common structural
cardiovascular finding attributable to SD in U.S. athletes is
hypertrophic cardiomyopathy (HCM), which is dispropor-
tionately more prevalent in African American athletes; in
fact, recent papers published by Maron et al. (5,6) showed
that nearly half of athletes who experienced SD were
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African American. In contrast, HCM is an infrequent
attributable cause of SD (1 of 51) of Italian athletes in the
current study. Second, the definition of a young competitive
athlete may not be consistent between the U.S. and Italy.
The study defines young competitive athletes as adolescents
and young adults who participated in an organized sports
program requiring regular training and competition (ac-
cording to Italian guidelines for sports medicine). The
terms, “organized sports program,” “training,” and “compe-
tition” are somewhat subjective and describe a wide range of
intensity and type of exercise, including such activities as
tennis, platform diving, fencing, and archery. On the same
theme, the competitive structure and training practices
around soccer in community settings can be quite different
from the competitive structure surrounding collegiate bas-
ketball or football. Whereas in the study by Corrado, the
most common competitive sport involved in SD was soccer,
the most common competitive sports involved in SD for
U.S. athletes are basketball and football. Recent findings
from Maron et al. (4) showed that about two-thirds of all
SDs in the U.S. were related to football or basketball. Third,
the genetic predisposition, dietary pattern, and environmen-
tal compositions of Italians are distinctly different from
those of Americans, even among adolescents and young
adults.
Another issue of interest is the apparent uniform quality
of the preparticipation screening and protocol required by
Italian law in contrast to the U.S., where exercise recom-
mendations to athletes are based largely on the intuition of
the individual physician. In the U.S., there is great regional
variation in the manner of preparticipation screening
compared with the Corrado study, but it must be remem-
bered that the Veneto region of Italy has a population of
a little more than four million people, roughly the same
as Cook County, Illinois or half the population of North
Carolina, a scale that lends itself to more uniformity and
coordination.
The American Heart Association recommends that
“[S]ome form of preparticipation cardiovascular screening
for high school and collegiate athletes is justifiable and
compelling, based on ethical, legal, and medical grounds.
Noninvasive testing can enhance the diagnostic power of
the standard history and physical examination; however, it is
not prudent to recommend routine use of such tests as
12-lead ECG, echocardiography, or graded exercise testing
for detection of cardiovascular disease in large populations
of athletes” (7).
The costs of such a strategy would be difficult to justify,
particularly because the accuracy of the echocardiographic
diagnosis of arrhythmogenic right ventricular dysplasia,
acquired cardiovascular disease, anomalous origin of the
coronary artery, and myocardial bridge depends greatly on
skill and experience in the performance and evaluation of
the echocardiographer. These lesions accounted for 30 of 46
deaths among the male athletes in this study. Furthermore,
5 of 46 deaths among the male athletes were attributed to
myocarditis, a condition that would likely occur after a
preparticipation evaluation. The economic and emotional
costs of universal laboratory screening would be increased by
false-positive findings and misinterpretation of the physio-
logic changes related to training, particularly in discriminat-
ing between physiologic increases in left ventricular wall
thickness and mass in the elite athlete and HCM. On the
other hand, given the higher proportion of HCM found
in U.S. athletes with SD, it is likely that a careful family
and personal history of cardiac symptoms, followed by
echocardiographic evaluation of all suspicious reports and
regular follow-up history of symptoms, would bring
about an improvement in the detection of individuals at
risk for SD with strenuous exercise (7–11). There will
always be borderline findings in which there is no mean-
ingful data to support whether or not restriction of such
individuals from competitive athletics would reduce their
risk for SD. In the absence of an unbiased exploration of
this question, clinical reason will have to suffice.
The difference between male and female risk for SD is
interesting and fertile soil for future study. There may be
differences in the risks for certain conditions, the time
course of disease, or the degree of myocardial hypertrophy.
Among other possible explanations are sociologic (reluc-
tance to complain of symptoms), economic (greater impact
on future wage-earning in high-profile sports), or atten-
tional factors (greater sensitivity to internal environment).
Whatever the cause of these differences, it is important to
avoid inappropriate applications of findings about one
gender to the other.
In light of the information provided by Corrado et al. (1),
we as cardiologists should press on with exploration of more
reliable and affordable methods of detecting individuals at
risk for SD during sports activities. This is a daunting task,
considering the wide variability in expertise in diagnosing
rare cardiac lesions and the immense economic pressure
placed on and by the sports industry in this country.
Nevertheless, this study illustrates that sensitive recognition
of cardiac abnormalities by preparticipation screening, if
followed by exclusion from competitive sports, will reduce
mortality from SD. It also demonstrates that the systematic
case finding and analysis within a comprehensive and
well-organized health care system, when fed back to the
practitioner through continuing education, can effect a
major improvement in detection of individuals at risk. This
knowledge will lead to an improved understanding of the
risks involved in athletic competition among individuals
with lesions predisposing to SD. The human and economic
costs of effective screening will undoubtedly be the subject
of studies for years to come. Second, for those individuals
considered at risk, the likelihood of SD is truly greater with
participation in competitive sports, a finding that must be
taken into consideration by individuals, the sports commu-
nity, educational systems, and health care providers.
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